Cocrystal Pharma Inc (COCP)
1.77
+0.06
(+3.51%)
USD |
NASDAQ |
Sep 27, 16:00
1.74
-0.03
(-1.69%)
After-Hours: 20:00
Cocrystal Pharma Free Cash Flow: -14.28M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -14.28M |
| March 31, 2024 | -16.14M |
| December 31, 2023 | -14.78M |
| September 30, 2023 | -16.30M |
| June 30, 2023 | -22.59M |
| March 31, 2023 | -20.76M |
| December 31, 2022 | -21.51M |
| September 30, 2022 | -19.53M |
| June 30, 2022 | -15.97M |
| March 31, 2022 | -14.89M |
| December 31, 2021 | -12.77M |
| September 30, 2021 | -12.22M |
| June 30, 2021 | -9.896M |
| March 31, 2021 | -9.584M |
| December 31, 2020 | -10.07M |
| September 30, 2020 | -8.919M |
| June 30, 2020 | -7.277M |
| March 31, 2020 | -5.982M |
| December 31, 2019 | -1.708M |
| September 30, 2019 | -2.462M |
| June 30, 2019 | -3.181M |
| March 31, 2019 | -4.242M |
| December 31, 2018 | -8.318M |
| September 30, 2018 | -7.913M |
| June 30, 2018 | -7.942M |
| Date | Value |
|---|---|
| March 31, 2018 | -6.941M |
| December 31, 2017 | -6.943M |
| September 30, 2017 | -7.666M |
| June 30, 2017 | -8.639M |
| March 31, 2017 | -12.73M |
| December 31, 2016 | -14.71M |
| September 30, 2016 | -15.56M |
| June 30, 2016 | -15.79M |
| March 31, 2016 | -13.15M |
| December 31, 2015 | -10.66M |
| September 30, 2015 | -9.25M |
| June 30, 2015 | -7.007M |
| March 31, 2015 | -5.801M |
| December 31, 2014 | -6.017M |
| September 30, 2014 | -5.072M |
| June 30, 2014 | -4.878M |
| March 31, 2014 | -4.518M |
| December 31, 2013 | -3.69M |
| September 30, 2013 | -2.663M |
| June 30, 2013 | -1.355M |
| March 31, 2013 | -0.515M |
| December 31, 2012 | -1.741M |
| September 30, 2012 | -2.755M |
| June 30, 2012 | -2.452M |
| March 31, 2012 | -2.687M |
Free Cash Flow Range, Past 5 Years
-22.59M
Minimum
Jun 2023
-1.708M
Maximum
Dec 2019
-12.88M
Average
-13.52M
Median
Free Cash Flow Benchmarks
| Perspective Therapeutics Inc | -24.58M |
| Alaunos Therapeutics Inc | -17.36M |
| Oragenics Inc | -7.214M |
| Cara Therapeutics Inc | -83.33M |
| Jaguar Health Inc | -29.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.699M |
| Free Cash Flow Per Share (Quarterly) | -0.3636 |
| Free Cash Flow Yield | -79.23% |